SKIA HEAD AR Surgical Guidance System Gains FDA Clearance
SKIA has received FDA 510(k) clearance for its augmented reality surgical guidance system, SKIA HEAD, announced in a press release. The clearance allows the company to begin commercial distribution of the system in the United States, supported by a hardware partnership with Structure.
SKIA HEAD is a tablet based platform that converts preoperative imaging data into three dimensional anatomical models. These models are projected onto the patient's body during surgery, allowing surgeons to visualize internal structures in real time. The system uses Structure Sensors to map the surgical environment and maintain precise alignment of the augmented overlay.
SKIA stated that the partnership with Structure will support its U.S. expansion by combining Structure's hardware with SKIA's software expertise. The company has previously deployed its SKIA Body solution in India and is conducting clinical trials for additional AR platforms, including SKIA Breast, in collaboration with major South Korean hospitals.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Avenda Health Brings Unfold AI Maps Into Prostate Surgery
Skan AI Named Leader in Everest Group's 2026 DII Assessment
Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
Coreline Soft Receives FDA Clearance for Aortic CT Analysis Software
Daily AI Brief: the AI news that matters, in your inbox.